Global Oseltamivir Market Size study & Forecast, by Product (Capsule, Suspension, Other Product Types), by Application (Influenza A Influenza B, Other Applications), and Regional Analysis, 2023-2030
Global Oseltamivir Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Oseltamivir, commonly known by its brand name Tamiflu, is an antiviral medication used to treat and prevent influenza (flu) infections caused by the influenza A and B viruses. It belongs to a class of drugs known as neuraminidase inhibitors. Oseltamivir works by inhibiting the activity of the neuraminidase enzyme, which is essential for the influenza virus to spread and infect other cells in the body. Oseltamivir helps to reduce the severity and duration of flu symptoms and also decreases the risk of complications associated with the flu, such as pneumonia. The Oseltamivir market is expanding because of factors such as the rising prevalence of influenza virus infections and the increase in the number of research and development activities.
Infection with the influenza virus is becoming more common. Since influenza is known to be a substantial source of illness and mortality in people, treatments have been developed and put into place to lessen the financial and medical load. For instance, according to the Centers for Disease Control and Prevention data, the influenza virus infection caused 8–13 million symptomatic illnesses, 3.7–6.1 million medical visits, 82,000–170,000 hospitalizations, and 5,000–14,000 fatalities from early October 2021 to mid-June 2022. Over 2.8 million respiratory specimens underwent testing in clinical labs for the influenza virus. 98.6% of specimens for influenza A and 1.4% for influenza B both tested positive overall, making up 4.5% of the total. A positive result for influenza was found in 0.1% to 9.9% of the samples per week. Additionally, according to WHO statistics released in February 2021, approximately 490,516 specimens were analyzed in 2021–2022 by WHO GISRS laboratories. Of these, 12,368 tested positive for the flu, with 8,423 having influenza A and 3,945 having influenza B. As a result, the high prevalence of influenza infection in the population is anticipated to enhance the demand for the medicine oseltamivir for its treatment, driving the market's expansion. In addition, government initiatives to increase access to oseltamivir and rising healthcare expenditures are creating lucrative opportunities for market growth. However, the side effects associated with oseltamivir treatment and availability of alternative treatments stifle market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Oseltamivir Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, the rising prevalence of diseases, the presence of well-established healthcare infrastructure, and rising spending on research and development activities. Whereas, Asia Pacific is projected to have significant growth owing to factors such as rising disease prevalence, rising government funding for drug development, and rising healthcare expenditure in the region.
Major market player included in this report are:
F. Hoffmann-La Roche Ltd
Cipla Inc.
Zydus Cadila
NATCO Pharma Limited
Macleods Pharmaceuticals Ltd
Amneal Pharmaceuticals LLC
Alembic Pharmaceuticals Limited
Hetero Healthcare Limited
Lupin Limited
Strides Pharma Science Limited
Recent Developments in the Market:
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Capsule
Suspension
Other Product Types
By Application:
Influenza A
Influenza B
Other Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Infection with the influenza virus is becoming more common. Since influenza is known to be a substantial source of illness and mortality in people, treatments have been developed and put into place to lessen the financial and medical load. For instance, according to the Centers for Disease Control and Prevention data, the influenza virus infection caused 8–13 million symptomatic illnesses, 3.7–6.1 million medical visits, 82,000–170,000 hospitalizations, and 5,000–14,000 fatalities from early October 2021 to mid-June 2022. Over 2.8 million respiratory specimens underwent testing in clinical labs for the influenza virus. 98.6% of specimens for influenza A and 1.4% for influenza B both tested positive overall, making up 4.5% of the total. A positive result for influenza was found in 0.1% to 9.9% of the samples per week. Additionally, according to WHO statistics released in February 2021, approximately 490,516 specimens were analyzed in 2021–2022 by WHO GISRS laboratories. Of these, 12,368 tested positive for the flu, with 8,423 having influenza A and 3,945 having influenza B. As a result, the high prevalence of influenza infection in the population is anticipated to enhance the demand for the medicine oseltamivir for its treatment, driving the market's expansion. In addition, government initiatives to increase access to oseltamivir and rising healthcare expenditures are creating lucrative opportunities for market growth. However, the side effects associated with oseltamivir treatment and availability of alternative treatments stifle market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Oseltamivir Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, the rising prevalence of diseases, the presence of well-established healthcare infrastructure, and rising spending on research and development activities. Whereas, Asia Pacific is projected to have significant growth owing to factors such as rising disease prevalence, rising government funding for drug development, and rising healthcare expenditure in the region.
Major market player included in this report are:
F. Hoffmann-La Roche Ltd
Cipla Inc.
Zydus Cadila
NATCO Pharma Limited
Macleods Pharmaceuticals Ltd
Amneal Pharmaceuticals LLC
Alembic Pharmaceuticals Limited
Hetero Healthcare Limited
Lupin Limited
Strides Pharma Science Limited
Recent Developments in the Market:
- In December 2022, The Administration for Strategic Preparedness and Response (ASPR) of the U.S. Department of Health and Human Services (HHS) has announced that it will make an additional supply of Tamiflu available to jurisdictions through the SNS.
- In January 2022, Strides Pharma Science Ltd received approval from the American health organisation to market its generic version of oseltamivir phosphate for oral suspension, a medication used to treat influenza-related illnesses. These would lead to rise the company market share.
- Historical Data – 2020 - 2021
- Base Year for Estimation – 2022
- Forecast period - 2023-2030
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered - Product, Application, Region
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Capsule
Suspension
Other Product Types
By Application:
Influenza A
Influenza B
Other Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Oseltamivir Market, by Region, 2020-2030 (USD Billion)
1.2.2. Oseltamivir Market, by Product, 2020-2030 (USD Billion)
1.2.3. Oseltamivir Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OSELTAMIVIR MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OSELTAMIVIR MARKET DYNAMICS
3.1. Oseltamivir Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of influenza virus infections
3.1.1.2. Increase in the number of research and development activities
3.1.2. Market Challenges
3.1.2.1. The side effects associated with oseltamivir treatment
3.1.2.2. Availability of alternative treatments
3.1.3. Market Opportunities
3.1.3.1. Government initiatives to increase access to oseltamivir
3.1.3.2. Rising healthcare expenditures
CHAPTER 4. GLOBAL OSELTAMIVIR MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL OSELTAMIVIR MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Oseltamivir Market by Product, Performance - Potential Analysis
5.3. Global Oseltamivir Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Oseltamivir Market, Sub Segment Analysis
5.4.1. Capsule
5.4.2. Suspension
5.4.3. Other Product Types
CHAPTER 6. GLOBAL OSELTAMIVIR MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Oseltamivir Market by Application, Performance - Potential Analysis
6.3. Global Oseltamivir Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Oseltamivir Market, Sub Segment Analysis
6.4.1. Influenza A
6.4.2. Influenza B
6.4.3. Other Applications
CHAPTER 7. GLOBAL OSELTAMIVIR MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Oseltamivir Market, Regional Market Snapshot
7.4. North America Oseltamivir Market
7.4.1. U.S. Oseltamivir Market
7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Oseltamivir Market
7.5. Europe Oseltamivir Market Snapshot
7.5.1. U.K. Oseltamivir Market
7.5.2. Germany Oseltamivir Market
7.5.3. France Oseltamivir Market
7.5.4. Spain Oseltamivir Market
7.5.5. Italy Oseltamivir Market
7.5.6. Rest of Europe Oseltamivir Market
7.6. Asia-Pacific Oseltamivir Market Snapshot
7.6.1. China Oseltamivir Market
7.6.2. India Oseltamivir Market
7.6.3. Japan Oseltamivir Market
7.6.4. Australia Oseltamivir Market
7.6.5. South Korea Oseltamivir Market
7.6.6. Rest of Asia Pacific Oseltamivir Market
7.7. Latin America Oseltamivir Market Snapshot
7.7.1. Brazil Oseltamivir Market
7.7.2. Mexico Oseltamivir Market
7.8. Middle East & Africa Oseltamivir Market
7.8.1. Saudi Arabia Oseltamivir Market
7.8.2. South Africa Oseltamivir Market
7.8.3. Rest of Middle East & Africa Oseltamivir Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. F. Hoffmann-La Roche Ltd
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Cipla Inc.
8.3.3. Zydus Cadila
8.3.4. NATCO Pharma Limited
8.3.5. Macleods Pharmaceuticals Ltd
8.3.6. Amneal Pharmaceuticals LLC
8.3.7. Alembic Pharmaceuticals Limited
8.3.8. Hetero Healthcare Limited
8.3.9. Lupin Limited
8.3.10. Strides Pharma Science Limited
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Oseltamivir Market, by Region, 2020-2030 (USD Billion)
1.2.2. Oseltamivir Market, by Product, 2020-2030 (USD Billion)
1.2.3. Oseltamivir Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OSELTAMIVIR MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OSELTAMIVIR MARKET DYNAMICS
3.1. Oseltamivir Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of influenza virus infections
3.1.1.2. Increase in the number of research and development activities
3.1.2. Market Challenges
3.1.2.1. The side effects associated with oseltamivir treatment
3.1.2.2. Availability of alternative treatments
3.1.3. Market Opportunities
3.1.3.1. Government initiatives to increase access to oseltamivir
3.1.3.2. Rising healthcare expenditures
CHAPTER 4. GLOBAL OSELTAMIVIR MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL OSELTAMIVIR MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Oseltamivir Market by Product, Performance - Potential Analysis
5.3. Global Oseltamivir Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Oseltamivir Market, Sub Segment Analysis
5.4.1. Capsule
5.4.2. Suspension
5.4.3. Other Product Types
CHAPTER 6. GLOBAL OSELTAMIVIR MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Oseltamivir Market by Application, Performance - Potential Analysis
6.3. Global Oseltamivir Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Oseltamivir Market, Sub Segment Analysis
6.4.1. Influenza A
6.4.2. Influenza B
6.4.3. Other Applications
CHAPTER 7. GLOBAL OSELTAMIVIR MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Oseltamivir Market, Regional Market Snapshot
7.4. North America Oseltamivir Market
7.4.1. U.S. Oseltamivir Market
7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Oseltamivir Market
7.5. Europe Oseltamivir Market Snapshot
7.5.1. U.K. Oseltamivir Market
7.5.2. Germany Oseltamivir Market
7.5.3. France Oseltamivir Market
7.5.4. Spain Oseltamivir Market
7.5.5. Italy Oseltamivir Market
7.5.6. Rest of Europe Oseltamivir Market
7.6. Asia-Pacific Oseltamivir Market Snapshot
7.6.1. China Oseltamivir Market
7.6.2. India Oseltamivir Market
7.6.3. Japan Oseltamivir Market
7.6.4. Australia Oseltamivir Market
7.6.5. South Korea Oseltamivir Market
7.6.6. Rest of Asia Pacific Oseltamivir Market
7.7. Latin America Oseltamivir Market Snapshot
7.7.1. Brazil Oseltamivir Market
7.7.2. Mexico Oseltamivir Market
7.8. Middle East & Africa Oseltamivir Market
7.8.1. Saudi Arabia Oseltamivir Market
7.8.2. South Africa Oseltamivir Market
7.8.3. Rest of Middle East & Africa Oseltamivir Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. F. Hoffmann-La Roche Ltd
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Cipla Inc.
8.3.3. Zydus Cadila
8.3.4. NATCO Pharma Limited
8.3.5. Macleods Pharmaceuticals Ltd
8.3.6. Amneal Pharmaceuticals LLC
8.3.7. Alembic Pharmaceuticals Limited
8.3.8. Hetero Healthcare Limited
8.3.9. Lupin Limited
8.3.10. Strides Pharma Science Limited
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Oseltamivir Market, report scope
TABLE 2. Global Oseltamivir Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Oseltamivir Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Oseltamivir Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Oseltamivir Market
TABLE 70. List of primary sources, used in the study of global Oseltamivir Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Oseltamivir Market, report scope
TABLE 2. Global Oseltamivir Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Oseltamivir Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Oseltamivir Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Oseltamivir Market
TABLE 70. List of primary sources, used in the study of global Oseltamivir Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Oseltamivir Market, research methodology
FIG 2. Global Oseltamivir Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Oseltamivir Market, key trends 2022
FIG 5. Global Oseltamivir Market, growth prospects 2023-2030
FIG 6. Global Oseltamivir Market, porters 5 force model
FIG 7. Global Oseltamivir Market, pest analysis
FIG 8. Global Oseltamivir Market, value chain analysis
FIG 9. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Oseltamivir Market, regional snapshot 2020 & 2030
FIG 15. North America Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 16. Europe Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Oseltamivir Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Oseltamivir Market, research methodology
FIG 2. Global Oseltamivir Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Oseltamivir Market, key trends 2022
FIG 5. Global Oseltamivir Market, growth prospects 2023-2030
FIG 6. Global Oseltamivir Market, porters 5 force model
FIG 7. Global Oseltamivir Market, pest analysis
FIG 8. Global Oseltamivir Market, value chain analysis
FIG 9. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Oseltamivir Market, regional snapshot 2020 & 2030
FIG 15. North America Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 16. Europe Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Oseltamivir Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
